<DOC>
	<DOCNO>NCT01166490</DOCNO>
	<brief_summary>This phase 1 , open-label , dose-escalation clinical trial evaluate safety tolerability ASG-5ME identify maximum tolerate dose patient pathologically confirm metastatic pancreatic adenocarcinoma , evaluate safety tolerability patient relapse refractory gastric adenocarcinoma .</brief_summary>
	<brief_title>A Phase 1 Dose Escalation Trial ASG-5ME Pancreatic Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Pathologically confirm metastatic pancreatic adenocarcinoma pathologically confirm AGS5positive gastric gastric esophageal junction adenocarcinoma Measurable disease ( least one nonresectable , nonnodal lesion great equal 10 mm long diameter nodal lesion great equal 15 mm short axis ) ECOG performance status 0 1 May untreated previously receive treatment pancreatic adenocarcinoma must relapse refractory disease follow 1 prior systemic therapy metastatic gastric adenocarcinoma . For patient previously receive treatment , must least 2 week since last systemic therapy radiation , least 4 week since treatment monoclonal antibody ( bevacizumab ) . Evidence history central nervous system metastases History another primary malignancy remission least 3 year Documented history cerebral vascular event , unstable angina , myocardial infarction , cardiac symptom consistent NYHA Class IIIIV within 6 month prior</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Monomethyl auristatin E ( MMAE )</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>AGS-5 Antigen</keyword>
	<keyword>SLC44A4 Antigen</keyword>
	<keyword>Gastric Neoplasms</keyword>
	<keyword>Pancreatic Neoplasms</keyword>
	<keyword>Antibody-Drug Conjugate</keyword>
	<keyword>Antibodies , Monoclonal</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>